From adult stem cells to cancer stem cells Oct-4 gene, cell-cell communication, and hormones during tumor promotion

Annals of the New York Academy of Sciences

Volumn 1089, Issue , 2006, Pages 36-58

  Trosko, James E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adult stem cells; Cancer stem cells; Gap junctional intercellular communication; Oct3 4 gene; Tumor promoter

Indexed keywords

GROWTH FACTOR; HORMONE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; ESTROGEN;

APOPTOSIS; BREAST CELL; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONFERENCE PAPER; EMBRYONIC STEM CELL; EPIDERMIS; GAP JUNCTION; GENE EXPRESSION; GROWTH REGULATION; HELA CELL; HOMEOSTASIS; HUMAN; KIDNEY CELL; LIVER CELL; MESENCHYME CELL; MITOGENESIS; NONHUMAN; ONCOGENE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PANCREAS CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STEM CELL; TUMOR CELL; TUMOR CELL LINE; TUMOR PROMOTION; ADULT STEM CELL; CELL TRANSFORMATION; CYTOLOGY; DRUG ANTAGONISM; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ADULT STEM CELLS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; ESTROGENS; HUMANS; NEOPLASMS; OCTAMER TRANSCRIPTION FACTOR-3; TUMOR STEM CELLS;

EID: 33847796969     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1386.018     Document Type: Conference Paper

References (69)

1. HANAHAN, D. & R.A. WEINBERG. 2000. The hallmarks of cancer. Cell 100: 57-70.
2. POTTER, V.R. 1978. Biochemistry of Cancer. In Cancer Research. J. Holland & E. Frei, Eds.: 178-192. Lea and Febiger. Philadelphia, PA.
3. MARKERT, C. 1968. Neoplasia: a disease of cell differentiation. Cancer Res. 28: 1908-1914.
4. PIERCE, G.P. 1974. Neoplasm differentiation and mutations. Am. J. Pathol. 77: 103-118.
5. POTTER, V.R. 1978. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. Br. J. Cancer 38: 1-23.
6. WEINSTEIN, I.B., C.S. GATTANI, P. KIRSCHMEIER, et al. 1984. Multistage carcinogenesis involves multiple genes and multiple mechanisms. J. Cell Physiol. Suppl. 3: 127-137.
7. FIALKOW, P.J. 1979. Clonal origin of human tumor. Am. Rev. Med. 30: 135-176.
8. TROSKO, J.E. & B.L. UPHAM. 2005. The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment. Mutagenesis 20: 81-90.
9. BEREBLUM, P.M. 1954. A speculative review: the probable nature of promoting action and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res. 14: 471-477.
10. MINSK, B. & K. ILLMENSI. 1976. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injecting into blastocysts. Proc. Natl. Acad. Sci. USA 73: 549-553.
11. DI GIOACCHINO, G., C. DI CAMPLI, M.A. ZOCCA, et al. 2005. Transdifferentiation of stem cells in pancreatic cells: state of the art. Transplant. Proc. 37: 2662-2663.
12. TROSKO, J.E. & C.C. CHANG. 1988. Nongenotoxic mechanisms in mechanisms in carcinogenesis: role of inhibited intercellular communication. In Banbury Report 31: Carcinogen Risk Assessment: New Directions in the Quantitative and Qualitative Aspects. R.W. Hart & F.D. Hoerger. Eds.: 139-170. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY.
13. TROSKO, J.E. & R.J. RUCH. 1998. Cell-cell communication in carcinogenesis. Front. Biosci. 3: 208-236.
14. GOODMAN, J.A. 2001. Operational reversibility is a key aspect of carcinogenesis. Toxicol. Sci. 64: 147-148.
15. TROSKO, J.E. & M.-H. TAI. 2006. Adult stem cell theory of the multistage, multimechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells. In Infection and Inflammation: Impacts on Oncogenesis. T. Dittmar, Ed.: 45-65. S. Karger AG. Amsterdam.
16. BURSCH, F., F. OBERHAMMER & R. SCHULTE- HERMANN. 1992. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13: 245-251.
17. UPHAM, B.L. & J. WAGNER. 2001. Toxicant-induced oxidative stress in cancer. Toxicol. Sci. 64: 1-3.
18. LOEWENSTEIN, W.R. 1966. Permeability of membrane junctions. Ann. N.Y. Acad. Sci. 137: 441-472.
19. WEI, C.-J., X. XU & C.W. LO. 2004. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 20: 811-838.
20. WILSON, M.R., T.W. CLOSE & J.E. TROSKO. 2000. Cell population dynamics (apoptosis, mitosis, and cell-cell communication) during disruption of homeostasis. Exp. Cell Res. 254: 257-268.
21. TROSKO, J.E. 2001. Is the concept of "tumor promotion" a useful paradigm? Mol. Carcinogen. 30: 131-137.
22. CERUTTI, P.A. 1985. Prooxidant states and tumor promotion. Science 227: 375-381.
23. UMEMURA, T., S. KAI, R. HASEGAWA, et al. 1999. Pentachlorophenol (PCP) produces liver oxidative stress and promoters but does not initiate hepatocarcinogenesis in B6C3F1 mice. Carcinogenesis 20: 1115-1120.
24. BHAT, H.K., G. CALAF, T. HEI, et al. 2003. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc. Natl. Acad. Sci. USA 100: 3913-3918.
25. BIRBOIM, H.C. 1982. DNA strand breakage in human leukocytes exposed to a tumor promoter, phorbol myristate acetate. Science 215: 1247-1249.
26. TROSKO, J.E. 1997. Challenge to the simple paradigm that "carcinogens" are "mutagens" and to the in vitro and in vivo assays used to test the paradigm. Mutat. Res. 373: 245-249.
27. TROSKO, J.E. 1988. A failed paradigm: carcinogenesis is more than mutagenesis. Mutagenesis 3: 363-366.
28. THILLY, W.G. 2003. Have environmental mutagens caused oncomutations in people? Nat. Genet. 255-259.
29. SELL, S. 1993. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ. Health Perspect. 101: 15-26.
30. COWAN, C., J. ATIENZA, D. MELTON, et al. 2005. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 1369-1373.
31. HAYFLICK, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614-636.
32. LAND, H., L.F. PARADA & R.A. WEINBERG. 1983. Tumorigenic conversion of primary embryo fibroblast requires at least at least two cooperating oncogenes. Nature 304: 596-602.
33. TROSKO, J.E., C.C. CHANG, M.R. WILSON, et al. 2000. Gap junctions and the regulation of cellular functions of stem cells during development and differentiation. Methods 20: 245-264.
34. MARKERT, C.L. 1984. Genetic control of cell interactions in chimeras. Develop. Genet. 4: 267-279.
35. TROSKO, J.E., C.C. CHANG, B.L. UPHAM, et al. 1998. Epigenetic toxicology as toxicant-induced changes in intracellular signaling leading to altered gap junctional intercellular communication. Toxicol. Lett. 102-103: 71-78.
36. TROSKO, J.E., C.C. CHANG, B.V. MADHUKAR, et al. 1996. Intercellular communication: a paradigm for the interpretation of the initiation/ promotion/progression model of carcinogenesis. In: Chemical Induction of Cancer: Modulation and Combination Effects. 205-225. Birkhauser, Boston.
37. BOREK, C. & L. SACHS. 1966. The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc. Natl. Acad. Sci. USA 56: 1705-1711.
38. TLSY, T.D., A. BRIOT, A. GUALBERTO, et al. 1995. Genomic instability and cancer. Mutation Res. 337: 1-7.
39. LOEWENSTEIN, W.R. 1966. Permeability of membrane junctions. Ann. N.Y. Acad. Sci., 137: 441-472.
40. TROSKO, J.E. 2003. The role of stem cells and gap junctional communication in carcinogenesis. J. Biochem Molec. Biol. 36: 43-48.
41. KING, T.J., L.H. FUKUSHIMA, T.A. DONLON, et al. 2000. Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications tumor progression. Carcinogenesis 21: 311-315.
42. MOMIYAMA, M., Y. OMORI, Y. ISHIZAKA, et al. 2003. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sci. 94: 501-507.
43. AL HAJJ, M., M.S. WICHA, A. BENITO-HERNANDEZ, et al. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100: 3983-3988.
44. PONTI, D., A. COSTA, N. ZAFFARONI, et al. 2005. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65: 5506-551.
45. TAI, M.H., C.C. CHANG, M. KIUPEL, et al. 2005. Oct-4 expression in adult stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26: 495-502.
46. CHANG, C.C. 2006. Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res. 8: 103-105.
47. KAO, C.Y., K. NOMATA, C.S. OAKLEY, et al. 1995. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characteristization and response to SV40 transfection. Carcinogenesis 16: 531-538.
48. KANG, K.S., W. SUN, K. NOMATA, et al. 1998. Involvement of tyrosine phosphorylation of p185 c-erB2/neu in tumorigenicity induced by X-rays and neuoncogene in human breast epithelial epithelial cells. Mol. Carcinogen. 21: 225-233.
49. CHANG, C.C., W. SUN, A. CRUZ, et al. 2001. A human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization. Cancer Res. 59: 6118-6123.
50. CHANG, C.C., W. SUN, A. CRUZ, et al. 2001. A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Radiat. Res. 155: 201-207.
51. PESCE, M. & H.R. SCHOLER. 2001. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19: 71-278.
52. MONK, M. & C. HOLDING. 2001. Human embryonic genes re-expressed in cancer cells. Oncogenes 20: 8085-8091
53. GIDEKEL, S., G. PIZOV, Y. BERGMAN, et al. 2003. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4: 361-370.
54. WEBSTER, J.D., V. YUSBASIYAN-GURKAN, C.C. CHANG, et al. 2005. Oct-4 expression in canine neoplasms: a potential role for embryonic genes in cancer progression. Vet. Pathol. 42: 5.
55. KANG, K.S., I. MORITA, A. CRUZ, et al. 1997. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformation cell lines. Carcinogenesis 18: 251-257.
56. GRUMMER, R., O. TRAUB & E. WINTERHAGER. 1999. Gap junction connexin genes cx26 and cx43 are differentially regulated by ovarian steroid hormones in rat endometrium. Endocrinology 140: 2509-2516.
57. SAITO, T., R. TANAKA, K. WATABA, et al. 2004. Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells. Oncogene 23: 1109-1116.
58. ASTRAHANTSEFF, K.N. & J.E. MORRIS. 1994. Estradiol-17 beta stimulates proliferation of uterine epithelial cells cultured with stromal cells but not cultured separately. In Vitro Cell Dev. Biol. 30: 769-776.
59. UPHAM, B.L. & J.E. TROSKO. 2005. A paradigm shift in the understanding of oxidative stress and its implications to exposure of low-level ionizing radiation. Acta Med. Nagasaki 50: 63-68.
60. CAVALIERI, E.L., D.E. STACK, P.D. DEVANESAN, et al. 1997. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 94: 10937-10942.
61. KLAUNIG, J.E. & L.M. KAMENDULIS. 2004. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44: 239-267.
62. SLAGA, T.J., A.J. KLEIN-SZANTO, L.L. TRIPLETT, et al. 1981. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213: 1023-1025.
63. KLEIN-SZANTO, A.J. & T.J. SLAGA. 1982. Effects of peroxides on rodent skin epidermal hyperplasia and tumor promotion. J. Invest. Dermatol. 79: 30-34.
64. NAKAMURA, Y., T.D. GINHART, D. WINTERSTEIN, et al. 1988. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis 9: 203-207.
65. KOIKE, T., N. KIMURA, K. MIYAZAKI, et al. 2004. Hypoxia induces adhesion molecules in cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc. Natl. Acad. Sci USA 101: 8132-8137.
66. ALLEN, R.G. 2000. Oxidative stress and gene regulation. Free Radic. Biol. Med. 28: 463-499.
67. TAMIR, S., S. IZRAEL & J. VAYA. 2002. The effect of oxidative stress on ER alpha and ER beta expression. J. Steroid Biochem. Molec. Biol. 81: 327-332.
68. TROSKO, J. et al. 1998. In Modern Cell Biology. Vol. 7: Gap Junctions. E.L. Hertberg and R.G. Johnson, Eds.: 435-488. Alan R. Liss. New York.
69. TROSKO, J.E. & T. INOUE. 1997. Oxidative stress, signal transduction, and intercellular communication in radiation carcinogenesis. In Radiation Injury and the Chernobyl Catastrophe. N. Daniak et al. Eds.: Alpha Med Press. Ohio; published as a supplement to Stem Cells 15(Suppl. 2): 59-67.